Table of Contents Author Guidelines Submit a Manuscript
Journal of Oncology
Volume 2010, Article ID 251208, 4 pages
http://dx.doi.org/10.1155/2010/251208
Clinical Study

Comorbidity-Adjusted Survival in Early Stage Lung Cancer Patients Treated with Hypofractionated Proton Therapy

Department of Radiation Medicine, Loma Linda University Medical Center, 11234 Anderson Street, Loma Linda, CA 92354, USA

Received 21 July 2010; Accepted 26 October 2010

Academic Editor: David Ball

Copyright © 2010 Sharon Y. Do et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Cancer Society, October 2008, http://www.cancer.org/Cancer/LungCancer-SmallCell/OverviewGuide/lung-cancer-small-cell-overview-key-statistics.
  2. A. J. Fakiris, R. C. McGarry, C. T. Yiannoutsos et al., “Stereotactic body radiation therapy for early-stage non–small-cell lung carcinoma: four-year results of a prospective phase II study,” International Journal of Radiation Oncology Biology Physics, vol. 75, no. 3, pp. 677–682, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. O. M. Salazar, T. S. Sandhu, P. B. Lattin et al., “Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced and 7 metastatic lung cancers,” International Journal of Radiation Oncology Biology Physics, vol. 72, no. 3, pp. 707–715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Uematsu, A. Shioda, A. Suda et al., “Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience,” International Journal of Radiation Oncology Biology Physics, vol. 51, no. 3, pp. 666–670, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. M. E. Charlson, P. Pompei, K. A. Ales, and C. R. MacKenzie, “A new method of classifying prognostic comorbidity in longitudinal studies: development and validation,” Journal of Chronic Diseases, vol. 40, no. 5, pp. 373–383, 1987. View at Google Scholar · View at Scopus
  6. D. A. Bush, J. D. Slater, B. B. Shin, G. Cheek, D. W. Miller, and J. M. Slater, “Hypofractionated proton beam radiotherapy for stage I lung cancer,” Chest, vol. 126, no. 4, pp. 1198–1203, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. Ö. Birim, A. P. W. M. Maat, A. P. Kappetein, J. P. Van Meerbeeck, R. A. M. Damhuis, and A. J. J. C. Bogers, “Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer,” European Journal of Cardio-Thoracic Surgery, vol. 23, no. 1, pp. 30–34, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. W. H. Hall, A. B. Jani, J. K. Ryu, S. Narayan, and S. Vijayakumar, “The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer,” Prostate Cancer and Prostatic Diseases, vol. 8, no. 1, pp. 22–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. W. H. Hall, R. Ramachandran, S. Narayan, A. B. Jani, and S. Vijayakumar, “An electronic application for rapidly calculating Charlson comorbidity score,” BMC Cancer, vol. 4, article no. 94, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. N. P. Rowell and C. J. Williams, “Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review,” Thorax, vol. 56, no. 8, pp. 628–638, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. F. B. Zimmermann, M. Bamberg, M. Molls, and B. Jeremic, “Radiation therapy alone in early stage non-small cell lung cancer,” Seminars in Surgical Oncology, vol. 21, no. 2, pp. 91–97, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Y. Chang, X. Zhang, X. Wang et al., “Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer,” International Journal of Radiation Oncology Biology Physics, vol. 65, no. 4, pp. 1087–1096, 2006. View at Publisher · View at Google Scholar · View at Scopus